Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 진크래머 한스 루돌프 하우스, 산도즈 리미티드filedCritical진크래머 한스 루돌프 하우스
Priority to KR1019880013638ApriorityCriticalpatent/KR900005991A/en
Publication of KR900005991ApublicationCriticalpatent/KR900005991A/en
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.
Claims (4)
리트로비루스에 의해 감염된 질병을 치료하기 위하여 적어도 하나의 약학적 담체 또는 희석제와 결합하여 유리염 또는 약학적 허용염 혹은 착염 형태로 옥트레오티드를 함유한 약학적 조성물.A pharmaceutical composition comprising octreotide in the form of a free salt or a pharmaceutically acceptable salt or complex salt in combination with at least one pharmaceutical carrier or diluent to treat a disease infected by Ritrovirus.제1항에 있어서, HIV-1 비루스에 의해 감염된 질병을 치료하는 약학적조성물.The pharmaceutical composition according to claim 1, which treats a disease infected by HIV-1 virus.제1항에 있어서, HIV-1 비루스의 복제를 억제하는 약학적 조성물.The pharmaceutical composition of claim 1, which inhibits replication of HIV-1 viruses.제1항에 있어서, AIDS를 치료하는 약학적 조성물.The pharmaceutical composition of claim 1, which treats AIDS.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION INCLUDING 3'-DEOXYTIMIDIN-2'-ENO- (3'-DESOXI-2 ', 3'-DIDESHIDROTIMIDINA) TO TREAT PATIENTS INFECTED WITH RETROVIRUS.